CXCR2 and neoplasm: Another study found PMN-MDSCs were the dominant infiltrating immune cell type in a prostate adenocarcinoma model driven by loss of Pten and Smad4 and pharmacologic inhibition of CXCR2 impeded tumor progression [236].